CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission ...

Cuba's Center for Genetic Engineering and Biotechnology (CIGB) highlighted today the use of national anti-COVID-19 vaccines ...

In a small trial, Mass General Brigham researchers found a drug designed to treat Celiac disease supported a more rapid ...

Increased risk of long COVID seen with financial hardship, food insecurity, less than a college education, lack of social support.

Imunon has confirmed the deprioritization of its COVID-19 vaccine program. With the company’s cash reserves falling below $5 ...

Pemivibart was well tolerated and prophylactic against COVID-19 infection among adult patients with significant immunocompromising conditions.

IN late June, the Scientific Advisory Group for the Origins of Novel Pathogens (SAGO), a group of independent experts convened by the World Health Organization (WHO), published an assessment of the ...

Romania experienced a significant surge in COVID-19 cases in July 2025, with 1,703 new infections reported—a 232% increase ...

The researchers followed participants from October 2024 to January 2025. Median age was 76 years, and 54.2% were women. By ...

Scientists have discovered a previously unknown virus in farmed Pacific oysters during a mass die-off in B.C., Canada.

Advancing this mission, Soligenix Inc. (NASDAQ: SNGX) is making strides with its HyBryte (TM) platform, a novel therapy aimed at treating cutaneous T-cell lymphoma (CTCL), a rare skin cancer that ...